Browse
Submit Data
Databases
API
Help

Dataset Information

12 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

(S)-3-Bromo-4-diallyl-amino-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

ABSTRACT: The title compound, C(20)H(30)BrNO(3), was obtained via a tandem asymmetric Michael addition-elimination reaction of 3,4-dibromo-5-(S)-(l-menth-yloxy)-2(5H)-furan-one and diallyl-amine in the presence of potassium fluoride. In the mol-ecule, the five-membered furan-one ring is approximately planar [maximum atomic deviation = 0.030?(3)?Å], and the six-membered cyclo-hexane ring adopts a chair conformation.

SUBMITTER: Fu JH

PROVIDER: S-EPMC3011618 | biostudies-literature | 2010 Nov

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

(S)-3-Bromo-4-diallyl-amino-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

Fu Jian-Hua JH Wang Zhao-Yang ZY Li Jian-Xiao JX Tan Yue-He YH

Acta crystallographica. Section E, Structure reports online 20101124 Pt 12

The title compound, C(20)H(30)BrNO(3), was obtained via a tandem asymmetric Michael addition-elimination reaction of 3,4-dibromo-5-(S)-(l-menth-yloxy)-2(5H)-furan-one and diallyl-amine in the presence of potassium fluoride. In the mol-ecule, the five-membered furan-one ring is approximately planar [maximum atomic deviation = 0.030 (3) Å], and the six-membered cyclo-hexane ring adopts a chair conformation. ...[more]

PMID: 21589558

Similar Datasets

(5S)-3-Chloro-4-diallyl-amino-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

Project description:The title compound, C(20)H(30)ClNO(3), was obtained via a tandem asymmetric Michael addition-elimination reaction of (5S)-3,4-dichloro-5-(l-menth-yloxy)-2(5H)-furan-one and diallyl-amine in the presence of potassium fluoride. The mol-ecular structure contains an approximately planar five-membered furan-one ring [maximum atomic deviation = 0.0221?(3)?Å] and a six-membered ring adopting a chair conformation.

| S-EPMC3213497 | biostudies-literature

3-Chloro-4-dimethyl-amino-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

Project description:The title compound, C(16)H(26)ClNO(3) contains one almost planar furan-one ring [maximum deviation of 0.021?(2)?Å for the O atom] with a stereogenic center (S) and one cyclo-hexane ring which displays a chair conformation and has three stereogenic centers [S at the C atom bearing the isopropyl group, R at the C atom attached to the O atom and R at the C atom bearing the methyl group].

| S-EPMC3120571 | biostudies-literature

(S)-3-Chloro-4-(4-ethyl-piperazin-1-yl)-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

Project description:The title compound, C(20)H(33)ClN(2)O(3), was obtained via a tandem asymmetric Michael addition-elimination reaction of 3,4-dichloro-5-(S)-(l-menth-yloxy)furan-2(5H)-one and 1-ethyl-piperazine in the presence of potassium fluoride. The mol-ecular structure contains an approximately planar five-membered furan-one ring [maximum atomic deviation = 0.024?(2)?Å] and two six-membered rings adopting chair conformations. Weak inter-molecular C-H?O hydrogen bonding is present in the crystal structure.

| S-EPMC3007345 | biostudies-literature

(5S)-3-Chloro-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]-4-(4-methyl-piperidin-1-yl)furan-2(5H)-one.

Project description:The title compound, C(20)H(32)ClNO(3), was obtained via a tandem asymmetric Michael addition-elimination reaction of (5S)-3,4-dichloro-5-(l-menth-yloxy)furan-2(5H)-one and 4-methyl-piperidine in the presence of potassium fluoride. The furan-one ring is approximately planar [maximum atomic deviation = 0.022 (2) Å] while the cyclo-hexane ring adopts a chair conformation. Weak inter-molecular C-H⋯O hydrogen bonding is present in the crystal structure.

| S-EPMC3051989 | biostudies-literature

(5S)-3-Chloro-4-(2,5-dihydro-1H-pyrrol-1-yl)-5-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]furan-2(5H)-one.

Project description:The title compound, C(18)H(26)ClNO(3), was obtained via a tandem asymmetric Michael addition-elimination reaction of 3,4-dichloro-5-(S)-(l-menth-yloxy)furan-2(5H)-one and 2,5-di-hydro-1H-pyrrole in the presence of potassium fluoride. In the mol-ecule, the nearly planar dihydro-pyrrole ring [maximum atomic deviation = 0.019?(3)?Å] is oriented at a dihedral angle of 10.73?(8)° to the the nearly planar furan-one ring [maximum atomic deviation = 0.011?(2)?Å]; the cyclo-hexane ring adopts a chair conformation. In the crystal, mol-ecules are linked via weak inter-molecular C-H?O hydrogen bonds, forming supra-molecular chains running along the b axis.

| S-EPMC3050327 | biostudies-literature

Crystal structure of 4-[(1R,2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yl] 2-methyl (2S,4S,5R)-1-[(2S,3R,5R)-5-meth-oxy-carbonyl-2-(2-methyl-phen-yl)pyrrolidine-3-carbon-yl]-5-(2-methyl-phen-yl)pyrrolidine-2,4-di-carboxyl-ate.

Project description:The title compound, C38H50N2O7, represents a chiral β-proline dipeptide. Corresponding stereogenic centres of constituting pyrrolidine units have opposite absolute configurations. The central amide fragment is planar within 0.1 Å and adopts a Z configuration along the N-CO bond. In the crystal, the hydrogen atoms of the methyl-ene groups form several short inter-molecular C-H⋯O contacts with the carbonyl oxygen atoms of an adjacent mol-ecule. The only active amino hydrogen atom is not involved in hydrogen bonding.

| S-EPMC6505609 | biostudies-literature

(5R*)-5-[(2S*,5S*)-1-Meth-oxy-5-phenyl-pyrrolidin-2-yl]-3-methyl-furan-2(5H)-one.

Project description:In the title compound, C16H19NO3, the pyrrolidine ring is in a twist conformation. The dihedral angle between the di-hydro-furan ring [maximum deviation = 0.0016?(11)?Å] and the phenyl ring is 47.22?(8)°. In the crystal, mol-ecules are linked by weak C-H?O hydrogen bonds, forming helical chains along the b-axis direction. The chains are further linked by C-H?? inter-actions to constitute a three-dimensional architecture.

| S-EPMC4158531 | biostudies-literature

(9H-Fluoren-9-yl)methyl N-{(2R,3R,4S)-4-hy-droxy-2-[(2S,5R)-2-isopropyl-5-methyl-cyclo-hex-yloxy]-5-oxooxolan-3-yl}carbamate propan-2-ol 0.334-solvate.

Project description:The title compound, C(29)H(35)NO(6).0.334C(3)H(8)O, a novel chiral N-(fluoren-9-yl-methyl-oxyxcarbon-yl) precursor, crystallizes with two independent carbamate (M) mol-ecules and propan-2-ol solvent mol-ecules in the unit cell. Its crystal structure has been determined from barely adequate data obtained from a multi-fragment needle crystal. In the crystal, N-H?O hydrogen bonds link M mol-ecules related by translation along the a axis into two independent chains. The ordered solvent mol-ecule, having a partial occupancy of 0.334, is attached to one independent M mol-ecule through O-H?O hydrogen bonds. The crystal packing exhibits weak inter-molecular C-H?O inter-actions and voids of 270?Å(3) filled with randomly disordered solvent mol-ecules which were handled using the SQUEEZE methodology.

| S-EPMC3275078 | biostudies-literature

6,12-Bis(hex-yloxy)-5H,11H-indolo[3,2-b]carbazole.

Project description:The title compound, C30H36N2O2, was prepared in a twofold Cadogan cyclization. The mol-ecule is located about a center of inversion. The indolocarbazole skeleton is essentially planar [maximum deviation = 0.028?(2)?Å], the C-N bond lengths are nearly identical and the C-C bond lengths of the pyrrole unit are significantly longer than those of the benzene subunits.

| S-EPMC3588340 | biostudies-literature

(1R,2S,5R)-(-)-Menthyl (S)-2-(methoxy-carbonyl)-benzene-sulfinate.

Project description:In the title chiral sulfinic acid ester, C18H26O4S, the cyclo-hexane ring of the menthyl fragment adopts a chair conformation. The mol-ecular shape is defined by the dihedral angle of 47.87?(8)° between the mean planes of the cyclo-hexane and benzene rings. In the crystal, mol-ecules related by the screw axis are connected into chains along [010] by weak Car-H?O=S contacts.

| S-EPMC3648263 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data